Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...
This second round of layoffs marks more than 300 employees let go within the year. Despite the cuts, health insurers are ...
Sanofi SNY and partner Regeneron REGN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending the approval of ...
France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...
The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for ...
Sanofi <a href=" target="_blank">(SASY.PA) is expected to post higher quarterly earnings this week, once more on the back of its star eczema treatment Dupixent as concerns linger about the future of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback